© 2019 by hemotune

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon

created by wyssraumdesign




Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to clinical application. We primarily focus on finding a targeted and efficient therapy for patients with sepsis, a devastating condition causing millions of deaths annually.

What started within the Functional Materials Laboratories of ETH Zurich soon developed to a growing company determined to develop life-saving therapies and change the world of medical technology.

Lukas Langenegger, CEO


Lukas is one of the founders of hemotune. He is deeply passionate to work at the interface between economics and research and to bring life-saving technologies from the research bench to the clinics.

After completing a banking apprenticeship and working for 2 years at UBS, Lukas decided to follow his passion and studied Chemical and Bioengineering at ETH Zurich and MIT. Lukas holds a M.Sc. degree in Chemical and Bioengineering from ETH Zurich and a diploma from the Swiss Bankers Association.

Dr. Carlos Mora, CSO


Carlos is one of the founders of hemotune. With his very interdisciplinary background in microbiology, immunology and bioengineering he perfectly complements the hemotune team.

During his studies at ETH Zurich, Carlos focused on the behavior and interaction of magnetic and non-magnetic nanoparticles in biological systems. He holds a Ph.D. degree in Chemical- and Bioengineering and an M.Sc. degree in Microbiology and Immunology, both from ETH Zurich, Switzerland.

Dr. Jean-Claude Metzger, Head of Product Development


Jean-Claude Metzger has joined hemotune in December 2017 as Head of Product Development, leading the development of hemotune’s blood purification device.


Before joining hemotune, he was responsible for hardware development of a post-analytics device for in-vitro diagnostics heading a team of engineers as Department Project Leader at Roche Diagnostics. Jean-Claude holds both an MSc and PhD in Mechanical Engineering from ETH Zurich.

Dr. Edouard Fonck, Head of Business Development


Edouard Fonck joined hemotune in March 2018 to lead the business development activities. Edouard has more than 14 years of experience in the life sciences and medical device area. Prior to joining hemotune, he worked for Endosense and Sequana Medical, where he was Business Development Director for markets in Europe and overseas. He is also the founder of Scitus Medical, a consulting service and incubator company in the medical device field. Edouard holds a PhD from the Ecole Polytechnique Federale de Lausanne and a bachelor degree in chemical engineering from the University of California at Santa Barbara.

Dr. Ursina Haltinner, Regulatory & Quality Manager


Ursina Haltinner joined hemotune in October 2018 as Regulatory and Quality Affairs Manager. Ursina brings along 10 years of experience in the health care industry. She started her career as regulatory affairs manager in the product development center of Synthes GmbH. Besides the medical device industry, she also provided regulatory support to biotechnology and pharmaceutical companies, taking care of the main markets such as the US and EU. Ursina holds a doctoral degree in veterinary medicine from Vetsuisse Faculty, Zurich.

Dr. Manuel Baumgartner, R&D Engineer


Manuel Baumgartner joined hemotune in November 2018 as an R&D Engineer. Manuel obtained his PhD in Materials Science from ETH Zurich, where he worked on nanomagnetism and spintronics devices. At hemotune he supports the device development team, focusing on testing and measuring magnetic nanoparticles. His doctoral thesis was nominated for the 2018 ETH Medal for outstanding PhD work.

Lorenz Poiger, R&D Engineer


Lorenz Poiger joined hemotune in March 2019 as an R&D Engineer. Lorenz holds a Bachelor’s degree from ZHAW in Mechanical Engineering majoring in Biomechanical Engineering. Throughout his studies he has developed and tested a lumbar spine disc implant for a customer in the medical field and gained experiences in product development including prototyping and manufacturing.

Prof. Dr. Wendelin Jan Stark

PhD, ETH Zurich

Prof. Stark is a leading scientist in the field of nanotechnology and is currently Professor at the Institute of Chemical and Bioengineering and head of the Functional Materials Laboratory at ETH Zurich. He has published about 300 scientific articles and is co-founder of several spin off companies.

Prof. Dr. Robert Grass

PhD, Turbobeads GmbH

Prof. Grass is an expert in development and manufacturing of magnetic nanoparticles he is co-founder and CEO of turbobeads PLC, which manufactures and sells magnetic nanoparticles for research and industrial applications. He is also Professor at ETH Zurich.

Prof. Dr. Inge Herrmann

PhD, EMPA, St. Gallen

Dr. Herrmann is an expert in medical applications of magnetic nanoparticles. She has authored several publications in magnetic blood purification and is currently group leader at the Swiss Federal Laboratories for Material Science and Technnology (EMPA).


We envision a future where the deep understanding of diseases allows targeted interventions for the most challenging medical needs. By being technology leaders in highly specific blood purification, hemotune provides the means to treat critically ill patients and save lives.

Invest in a life-saving therapy.

You want to know more about our innovation?